NEW YORK (GenomeWeb) – DeNovo Sciences today announced a collaborative research agreement with South Texas Accelerated Research Therapeutics (START) to perform whole-genome sequencing on circulating tumor cells.

Under the terms of the agreement, START will collect blood from cancer patients and use DeNovo instruments and reagents for CTC enrichment and purification. The enriched CTCs will then be sent to a lab for whole-genome sequencing.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.